Department of Gastroenterology and Hepatology, Medical University of Gdansk, Smoluchowskiego 17, 80-214, Gdansk, Poland.
Surg Endosc. 2018 Dec;32(12):4939-4952. doi: 10.1007/s00464-018-6255-4. Epub 2018 Jun 4.
The place of endoscopic techniques in the treatment of main pancreatic duct (MPD) disruption arising in the course of acute necrotizing pancreatitis (ANP) remains unclear. The aim of this study was to describe the findings of endoscopic retrograde pancreatography (ERP) in patients with walled-off necrosis (WON). It was attempted to evaluate the role of endoscopic treatment of pancreatic duct disruption in patients with WON.
The retrospective analysis of results and complications with particular emphasis to all ERP procedures in the group of 226 patients was conducted, which underwent endoscopic treatment of symptomatic WON between years 2001 and 2016 in the Department of Gastroenterology and Hepatology of Medical University of Gdańsk.
ERP was performed in 204/226 (90.27%) patients. Partial and complete disruption of the MPD were identified in 103 (50.49%) and 63 (30.89%) out of 204 patients, respectively. Endoscopic treatment was used in all 166 patients with MPD disruption. The success of endoscopic treatment of MPD disruption was achieved in 138/161 (85.71%) patients with WON. The therapeutic success of WON endotherapy was achieved in 214/226 (94.69%) patients. The mean follow-up duration was 56 (SD = 37.06) [range 14-158] months. Long-term success of treatment of WON was achieved in 182/226 (80.53%) patients.
MPD disruption occurs in the majority of patients with WON. Partial disruption of the MPD is more frequent than complete disruption of the duct. This study conducted on a large group of patients demonstrated that prosthesis insertion into the MPD in patients with disruption of the MPD in the course of ANP is one of the key elements in endoscopic treatment of WON. Passive transpapillary drainage is an effective method of treating MPD disruptions, which improves long-term outcomes of endoscopic treatment in patients with WON.
内镜技术在治疗急性坏死性胰腺炎(ANP)过程中出现的主胰管(MPD)破裂中的地位仍不清楚。本研究的目的是描述内镜逆行胰胆管造影(ERP)在壁龛性坏死(WON)患者中的发现。尝试评估内镜治疗 WON 患者胰管破裂的作用。
对 2001 年至 2016 年间在格但斯克医科大学胃肠病学和肝脏病学系接受内镜治疗症状性 WON 的 226 例患者的结果和并发症进行回顾性分析。
204/226(90.27%)例患者进行了 ERP。204 例患者中,103 例(50.49%)和 63 例(30.89%)分别存在 MPD 部分和完全破裂。166 例 MPD 破裂患者均采用内镜治疗。138/161(85.71%)例 WON 患者 MPD 破裂的内镜治疗成功。226 例患者中,214 例(94.69%)WON 患者行内镜治疗成功。平均随访时间为 56(SD=37.06)[14-158]个月。182/226(80.53%)例患者实现了 WON 的长期治疗成功。
MPD 破裂发生在大多数 WON 患者中。MPD 的部分破裂比完全破裂更为常见。本研究对一大组患者进行了研究,表明在 ANP 过程中 MPD 破裂的患者中插入 MPD 支架是内镜治疗 WON 的关键要素之一。被动经乳头引流是治疗 MPD 破裂的有效方法,可改善 WON 患者内镜治疗的长期结果。